Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...

Wegovy (semaglutide), a glucagon-like peptide-1 (GLP-1) receptor agonist, was first approved by the Food and Drug Administration ... provides to narrow down our list even further.

Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of ...

It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

Curious about how you can use AI to make a better grocery list? Here are some ideas: Remember: AI models are multimodal, ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

The diabetes and weight loss medications Ozempic and Wegovy are now ... in shortage by the Food and Drug Administration (FDA). While the drugs remain on the shortage list for now, they are no ...